Shi, Y. .; Li, Y. .; Chen, W. .; Zhang, M. .; Qian, D. .; Li, T. .; Dai, Y. .; Li, G. . Cost-Effectiveness Analysis of Sintilimab Vs. Docetaxel As the Second-Line Therapy of Squamous Non-Small Cell Lung Cancer in China. Health Decision 2024, 2.